InvestorsObserver
×
News Home

Should You Buy West Pharmaceutical Services Inc. (WST) Stock After it Is Higher By 1.56% in a Week?

Monday, November 13, 2023 03:29 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy West Pharmaceutical Services Inc. (WST) Stock After it Is Higher By 1.56% in a Week?

The market has been high on West Pharmaceutical Services Inc. (WST) stock recently. WST gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
West Pharmaceutical Services Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on WST!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With WST Stock Today?

West Pharmaceutical Services Inc. (WST) stock is lower by -1.16% while the S&P 500 has risen 0.04% as of 3:22 PM on Monday, Nov 13. WST is down -$3.97 from the previous closing price of $342.19 on volume of 241,160 shares. Over the past year the S&P 500 has gained 11.62% while WST has risen 39.58%. WST earned $7.41 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 45.6. To screen for more stocks like West Pharmaceutical Services Inc. click here.

More About West Pharmaceutical Services Inc.

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States. Click Here to get the full Stock Report for West Pharmaceutical Services Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App